Creative Biolabs Announces New Solutions to Move mRNA Therapeutics Forward

October 20 05:49 2022
Entrenched in pre-clinical drug development for years, Creative Biolabs has acquired accumulating experience in mRNA-based therapeutics and is committed to providing a series of services and products regarding mRNA therapy.

New York, USA – October 20, 2022 – Recently, researchers from Oregon State University and Oregon Health & Science University have utilized lipid nanoparticles for mRNA delivery to cancer clusters, demonstrating that combined therapy, mRNA-based and cisplatin therapeutics, result in prolonged lifespan and reduced atrophy of muscles in vivo than that of mice with singular therapy. In addition, this observation further showcased those past decades of research exploring the therapeutic value of mRNA were well deserved. Meanwhile, Creative Biolabs has worked hard to strengthen and perfect its capabilities for mRNA research, covering mRNA technology, mRNA products, and mRNA services.

The swift delivery of the world’s first COVID-19 vaccine put a big spotlight on the promise of mRNA technology. “LPR technology is one of the most widely used mRNA technologies, and immunization with LPR showed superior effectiveness in controlling tumor growth,” a scientist at Creative Biolabs said, “and we are working hard to propel the potential of this technology forward with our robust and rapid manufacturing abilities.”

Below are some advantages of the LPR technology at Creative Biolabs:

* Combining beneficial properties of lipid-based and polymer-based nanoparticles

* Reduced cellular toxicity

* Greater colloidal stability

In addition, cytokine mRNA is essential for mRNA-based therapeutic development due to its ability to mediate and regulate immunity, inflammation, and hematopoiesis. Creative Biolabs provides customers with high-quality cytokine mRNA, synthesized utilizing the IVTScrip™ platform that encodes various cytokines in vivo and in vitro, facilitating research into relevant physiological mechanisms and the study of drugs for diseases related to cytokine regulation mechanisms.

Creative Biolabs’ leading cytokine mRNA products include:


* PF4

* IFN-γ

* IL-4

* CD257

Also, Creative Biolabs offers custom mRNA products that are specifically modified according to research needs.

Meanwhile, in order to enhance the stability of natural mRNA and reduce immunogenicity, Creative Biolabs provides researchers with custom mRNA modification services, which can minimize the risk of mutagen and carcinogen effects of mRNA products. “We’ll send experienced and qualified scientists to apply flexible modification approaches for mRNA products and provide the best after-sales service,” a director of Creative Biolabs said. In addition to mRNA modification, Creative Biolabs also provides custom mRNA synthesis and custom mRNA delivery development for global researchers.

Learn more about Creative Biolabs’ mRNA therapeutic solutions at

About Creative Biolabs

Creative Biolabs is a full-contract manufacturer that can assist with mRNA therapeutic development. Armed with innovative technologies, well-allocated resources, and a group of talented scientific minds, Creative Biolabs is dedicated to providing the best service and pursuit of being a reliable partner in the mRNA area.

Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-830-6441
Country: United States